Mark Petrie is Professor of Cardiology at the University of Glasgow,
Glasgow, UK. In Glasgow Royal Infirmary he runs a broad-ranging heart
failure service alongside nurses and pharmacists. He also is a member
of the Scottish National Advanced Heart Failure team at the Golden
Jubilee National Hospital, Clydebank, UK, which he directed until
He is in leadership positions of many trials, including STICH,
REVIVED, EMPACT-MI, STEP-HF, REDUCE-LAP, Dapa-HF, PARADISE-MI,
RELIEHF-HF, FINEARTS, and IRONMAN. Professor Petrie has published over
200 manuscripts, including many in journals such as the New England
Journal of Medicine, The Lancet, Circulation, JACC
and the European Heart Journal.
His clinical and research interests in diabetes and heart failure began in 2006. He was a senior author of the 2018 European Society of Cardiology (ESC) heart failure and diabetes consensus statement, an author of the ESC NSTEMI Guidelines and a reviewer of the 2016 ESC HF Guidelines. Prof. Petrie has chaired or been a member of the clinical events committees of EMPA REG-OUTCOME, CARMELINA, CAROLINA, DELIVER as well as around 30 other trials.